Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Electroacupuncture vs Solifenacin for Female Overactive Bladder
NCT05798403Recruiting
- Start
- Jul 2023
- Primary completion
- Aug 2025
- Countries
- 1
01
Overview
Randomised, double-blind trial (2 arms). Primary endpoint: Percentage change in the number of voids every 24 hours at 4 weeks. Started Jul 2023; status: recruiting.
Beyond the preview
Go deeper on NCT05798403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05798403.